Sponsor Pipeline

Nuvig Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07095127 Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune… Immune Thrombocytopenia (ITP) Recruiting
NCT07027111 Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP Chronic Inflammatory Demyelinating Polyneuropathy Active, Not Recruiting
Get alerts when Nuvig Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free